2025
Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidance
Jiang W, Gan D, Johnson M, Latich I, Lee F. Advancements in minimally invasive interventional oncology procedures for painful sacral metastases under imaging guidance. EngMedicine 2025, 2: 100051. DOI: 10.1016/j.engmed.2024.100051.Peer-Reviewed Original ResearchPainful sacral metastasesIntra-operative image guidanceSacral metastasesImage guidancePreoperative baselineFollow-upPercutaneous interventionFunction scoresLong-term follow-upRisk of cement leakageO-arm navigationImprovement of painRetrospective cohort reviewImage guidance techniquesAverage follow-upInterventional oncology proceduresIntra-operative imaging techniquesO-armPercutaneous ablationSingle-institutionCohort reviewPrimary cancerClinical improvementMultiple myelomaCement leakage401 Prognostic Value of Pelvic Washing Cytology in Early-Stage Endometrial Cancer: A 10-Year Single-Institute Cohort Study
Wang M, Abi-Raad R, Krishnamurti U, Cai G, Adeniran A, Sun T. 401 Prognostic Value of Pelvic Washing Cytology in Early-Stage Endometrial Cancer: A 10-Year Single-Institute Cohort Study. Laboratory Investigation 2025, 105: 102628. DOI: 10.1016/j.labinv.2024.102628.Peer-Reviewed Original Research
2024
Progression of Femoral Osteolytic Metastases after Intramedullary Nailing and Subsequent Salvage Techniques
Jiang W, Latich I, Lindskog D, Friedlaender G, Lee F. Progression of Femoral Osteolytic Metastases after Intramedullary Nailing and Subsequent Salvage Techniques. Cancers 2024, 16: 2812. PMID: 39199585, PMCID: PMC11352437, DOI: 10.3390/cancers16162812.Peer-Reviewed Original ResearchPre-existing lesionsOsteolytic metastasesIntramedullary nailingCancer progressionTwo-week postoperative follow-upFollow-upSalvage techniqueFunction scoresRadiation-resistant tumorsPoor surgical candidacyPostoperative follow-upNail failureTransport of cancer cellsPostoperative radiationSurgical salvageCombined painSingle-institutionSurgical outcomesIntramedullary nail insertionPathological fracturesRetrospective studySurgical candidacyAdult patientsPercutaneous salvageOsteolytic lesionsNeoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis
Johnson B, Teply B, Kagemann C, McGuire B, Lombardo K, Jing Y, Langbo W, Epstein J, Netto G, Baras A, Matoso A, McConkey D, Gupta A, Ahuja N, Ross A, Pierorazio P, Comperat E, Hoffman-Censits J, Singla N, Patel S, Kates M, Choi W, Bivalacqua T, Hahn N. Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer 2024, 10: 133-143. PMID: 39131872, PMCID: PMC11308648, DOI: 10.3233/blc-240008.Peer-Reviewed Original ResearchExpression of immune checkpointsClinical activityNeoadjuvant cisplatinImmune checkpointsT cellsIncreased expression of immune checkpointsTranscriptome RNA sequencingMuscle-invasive patientsPegfilgrastim 6 mgAggressive histologic subtypePathological complete responseUrothelial bladder cancerT cell genesBasal-squamousYpCR rateNeoadjuvant therapyComplete responseHistological subtypesSingle-institutionUrothelial cancerPrimary endpointUrothelial tumorsTumor biologyBladder cancerGrade 3
2013
Single-institution Outcome Experience Using AlloDerm® as Temporary Coverage or Definitive Reconstruction for Cutaneous and Soft Tissue Malignancy Defects
Deneve J, Turaga K, Marzban S, Puleo C, Sarnaik A, Gonzalez R, Sondak V, Zager J. Single-institution Outcome Experience Using AlloDerm® as Temporary Coverage or Definitive Reconstruction for Cutaneous and Soft Tissue Malignancy Defects. The American Surgeon 2013, 79: 476-482. PMID: 23635582, PMCID: PMC4505800, DOI: 10.1177/000313481307900522.Peer-Reviewed Original ResearchMeSH KeywordsAcellular DermisAdultAgedAged, 80 and overCarcinomaCellulitisCollagenDermatofibrosarcomaFemaleHumansMaleMelanomaMiddle AgedPlastic Surgery ProceduresPostoperative ComplicationsRetrospective StudiesSkin NeoplasmsSkin TransplantationSoft Tissue NeoplasmsSurgical FlapsTreatment OutcomeWound HealingConceptsAlloDerm reconstructionInstitutional review board-approved review of patientsDefinitive reconstructionInstitutional review board-approved reviewReview of patientsHead and neckSoft tissue malignancyMedian defect sizeSoft tissue resectionSplit-thickness skin graftEarly postoperative findingsComplex surgical defectsSoft tissue defectsAdjuvant radiationPositive marginsOral antibioticsSingle-institutionClinicopathological variablesCosmetic outcomePostoperative examinationFrequent complicationPostoperative findingsMalignant defectsSurgical defectsTissue malignancy
2003
Accurate Lymph Node Staging is of Greater Prognostic Importance Than Subclassification of the T2 Category for Gastric Adenocarcinoma
Sarela A, Turnbull A, Coit D, Klimstra D, Brennan M, Karpeh M. Accurate Lymph Node Staging is of Greater Prognostic Importance Than Subclassification of the T2 Category for Gastric Adenocarcinoma. Annals Of Surgical Oncology 2003, 10: 783-791. PMID: 12900370, DOI: 10.1245/aso.2003.09.009.Peer-Reviewed Original ResearchConceptsMuscularis propriaGastric adenocarcinomaPrognostic factorsAccurate lymph node stagingDepth of mural invasionPrevalence of nodal metastasesStaging of gastric adenocarcinomaAccurate nodal stagingLymph node stagingFive-year survivalNodal stagingPT2 tumorsR0 resectionNodal metastasisAccurate stagingPrognostic discriminationNode stagingPN categorySingle-institutionMural invasionPrognostic importanceT2 categoryTumor siteLymph nodesPoor survival
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply